(1->4)-beta-D-glucan multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A30 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO Slc25a30 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of SLC25A30 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO Slc25a30 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of SLC25A30 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of SLC25A30 mRNA CTD PMID:25380136 and PMID:30723492 17beta-estradiol decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Estradiol results in decreased expression of SLC25A30 mRNA CTD PMID:21185374 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC25A30 mRNA CTD PMID:35192832 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of SLC25A30 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of SLC25A30 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A30 mRNA CTD PMID:26232522 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO SLC25A30 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A30 mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc25a30 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A30 mRNA CTD PMID:21570461 and PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc25a30 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A30 mRNA CTD PMID:19770486 and PMID:21889950 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc25a30 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A30 mRNA CTD PMID:18172886 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of SLC25A30 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SLC25A30 mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of SLC25A30 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO Slc25a30 (Mus musculus) 6480464 bisphenol S results in increased expression of SLC25A30 mRNA CTD PMID:33297965 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of SLC25A30 mRNA CTD PMID:28959563 Actein decreases expression EXP 6480464 actein results in decreased expression of SLC25A30 protein CTD PMID:29969672 aflatoxin B1 increases expression ISO Slc25a30 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of SLC25A30 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SLC25A30 mRNA CTD PMID:25378103 amiodarone increases expression ISO SLC25A30 (Homo sapiens) 6480464 Amiodarone results in increased expression of SLC25A30 mRNA CTD PMID:19774075 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC25A30 gene CTD PMID:35440735 benzo[a]pyrene decreases expression ISO Slc25a30 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A30 mRNA CTD PMID:19770486 and PMID:32417428 benzo[a]pyrene decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A30 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO SLC25A30 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC25A30 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO SLC25A30 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC25A30 5' UTR CTD PMID:27901495 bisphenol A decreases expression ISO Slc25a30 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC25A30 mRNA CTD PMID:26063408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC25A30 mRNA CTD PMID:35192832 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC25A30 mRNA CTD PMID:25181051 more ... bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of SLC25A30 mRNA CTD PMID:32479839 chlorpyrifos decreases expression ISO Slc25a30 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of SLC25A30 mRNA CTD PMID:37019170 choline multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 cisplatin increases expression ISO SLC25A30 (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC25A30 mRNA CTD PMID:27392435 clofibrate increases expression ISO Slc25a30 (Mus musculus) 6480464 Clofibrate results in increased expression of SLC25A30 mRNA CTD PMID:23811191 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of SLC25A30 mRNA CTD PMID:32741897 crocidolite asbestos decreases expression ISO Slc25a30 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of SLC25A30 mRNA CTD PMID:29279043 cyanocob(III)alamin multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 cyclosporin A decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC25A30 mRNA CTD PMID:25562108 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC25A30 mRNA CTD PMID:23640034 dexamethasone increases expression ISO Slc25a30 (Mus musculus) 6480464 Dexamethasone results in increased expression of SLC25A30 mRNA CTD PMID:22733784 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC25A30 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO Slc25a30 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of SLC25A30 mRNA CTD PMID:28962523 diclofenac decreases expression ISO Slc25a30 (Mus musculus) 6480464 Diclofenac results in decreased expression of SLC25A30 mRNA CTD PMID:26934552 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SLC25A30 mRNA CTD PMID:17005392 disodium selenite increases expression ISO SLC25A30 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of SLC25A30 mRNA CTD PMID:24383545 diuron increases expression EXP 6480464 Diuron results in increased expression of SLC25A30 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A30 mRNA CTD PMID:27188386 entinostat increases expression ISO SLC25A30 (Homo sapiens) 6480464 entinostat results in increased expression of SLC25A30 mRNA CTD PMID:27188386 epoxiconazole affects expression ISO Slc25a30 (Mus musculus) 6480464 epoxiconazole affects the expression of SLC25A30 mRNA CTD PMID:35436446 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of SLC25A30 mRNA CTD PMID:32741897 fluoranthene multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A30 mRNA CTD PMID:28329830 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC25A30 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 furan decreases expression EXP 6480464 furan results in decreased expression of SLC25A30 mRNA CTD PMID:26194646 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of SLC25A30 mRNA CTD PMID:17785943 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC25A30 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SLC25A30 mRNA CTD PMID:24136188 glycine betaine multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A30 mRNA CTD PMID:22129741 inulin multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC25A30 mRNA CTD PMID:36331819 isoprenaline increases expression ISO Slc25a30 (Mus musculus) 6480464 Isoproterenol results in increased expression of SLC25A30 mRNA CTD PMID:20003209 L-methionine multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 methylmercury chloride decreases expression ISO SLC25A30 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SLC25A30 mRNA CTD PMID:23179753 and PMID:27188386 mono(2-ethylhexyl) phthalate decreases expression ISO Slc25a30 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of SLC25A30 mRNA CTD PMID:22401849 N-nitrosodiethylamine increases expression ISO Slc25a30 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of SLC25A30 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC25A30 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLC25A30 mRNA CTD PMID:24535843 N-nitrosodimethylamine affects expression EXP 6480464 Dimethylnitrosamine affects the expression of SLC25A30 mRNA CTD PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SLC25A30 mRNA CTD PMID:24136188 nickel sulfate decreases expression ISO SLC25A30 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of SLC25A30 mRNA CTD PMID:22714537 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLC25A30 mRNA CTD PMID:23439660 paracetamol affects expression ISO Slc25a30 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC25A30 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC25A30 mRNA CTD PMID:33387578 paracetamol increases expression ISO SLC25A30 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC25A30 mRNA CTD PMID:29067470 paracetamol decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC25A30 mRNA CTD PMID:25704631 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A30 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of SLC25A30 mRNA CTD PMID:19162173 perfluorooctanoic acid increases expression ISO SLC25A30 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of SLC25A30 mRNA CTD PMID:32588087 phenobarbital decreases expression ISO Slc25a30 (Mus musculus) 6480464 Phenobarbital results in decreased expression of SLC25A30 mRNA CTD PMID:19482888 phenobarbital multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLC25A30 mRNA CTD PMID:24535843 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of SLC25A30 mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A30 mRNA CTD PMID:18489776 pirinixic acid affects expression ISO Slc25a30 (Mus musculus) 6480464 pirinixic acid affects the expression of SLC25A30 mRNA CTD PMID:23811191 pirinixic acid increases expression ISO Slc25a30 (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC25A30 mRNA CTD PMID:17426115 and PMID:18301758 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC25A30 mRNA CTD PMID:19162173 and PMID:32741897 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of SLC25A30 mRNA CTD PMID:19162173 quercetin increases expression ISO SLC25A30 (Homo sapiens) 6480464 Quercetin results in increased expression of SLC25A30 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO SLC25A30 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SLC25A30 mRNA CTD PMID:30851411 riddelliine decreases expression EXP 6480464 riddelliine results in decreased expression of SLC25A30 mRNA CTD PMID:18047722 SB 431542 multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A30 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO Slc25a30 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of SLC25A30 mRNA CTD PMID:23221170 sodium arsenate increases expression ISO Slc25a30 (Mus musculus) 6480464 sodium arsenate results in increased expression of SLC25A30 mRNA CTD PMID:30953684 sodium arsenite increases expression ISO Slc25a30 (Mus musculus) 6480464 sodium arsenite results in increased expression of SLC25A30 mRNA CTD PMID:22700541 sodium arsenite affects expression ISO Slc25a30 (Mus musculus) 6480464 sodium arsenite affects the expression of SLC25A30 mRNA CTD PMID:25825268 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of SLC25A30 mRNA CTD PMID:25993096 sunitinib increases expression ISO SLC25A30 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC25A30 mRNA CTD PMID:31533062 tamoxifen affects expression ISO Slc25a30 (Mus musculus) 6480464 Tamoxifen affects the expression of SLC25A30 mRNA CTD PMID:20937368 testosterone increases expression ISO Slc25a30 (Mus musculus) 6480464 Testosterone results in increased expression of SLC25A30 mRNA CTD PMID:21669218 testosterone decreases expression ISO Slc25a30 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of SLC25A30 mRNA CTD PMID:33848595 tetrachloroethene increases expression ISO Slc25a30 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of SLC25A30 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO Slc25a30 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC25A30 mRNA CTD PMID:27339419 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC25A30 mRNA CTD PMID:30723492 and PMID:31150632 tetracycline increases expression ISO Slc25a30 (Mus musculus) 6480464 Tetracycline results in increased expression of SLC25A30 mRNA CTD PMID:16917069 thalidomide decreases expression ISO Slc25a30 (Mus musculus) 6480464 Thalidomide results in decreased expression of SLC25A30 mRNA CTD PMID:26217789 trichostatin A increases expression ISO SLC25A30 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLC25A30 mRNA CTD PMID:24935251 trichostatin A affects expression ISO SLC25A30 (Homo sapiens) 6480464 trichostatin A affects the expression of SLC25A30 mRNA CTD PMID:28542535 troglitazone decreases expression ISO Slc25a30 (Mus musculus) 6480464 troglitazone results in decreased expression of SLC25A30 mRNA CTD PMID:28973697 valproic acid affects expression ISO SLC25A30 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC25A30 mRNA CTD PMID:25979313 valproic acid increases expression ISO SLC25A30 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC25A30 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO SLC25A30 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A30 mRNA CTD PMID:27188386 vorinostat increases expression ISO SLC25A30 (Homo sapiens) 6480464 vorinostat results in increased expression of SLC25A30 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593 zinc(0) multiple interactions ISO Slc25a30 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of SLC25A30 mRNA CTD PMID:33549593